Biocon Licenses Seven In Asia To DKSH

Indian Firm’s Generics To Reach Singapore And Thailand

Keen to make strides for its growing Small Molecules business, Biocon has signed an agreement with DKSH to bring seven generic formulations to markets in South East Asia.

South East Asia
Biocon's deal with DKSH will take seven generics to markets in South East Asia • Source: Shutterstock

Biocon has licensed sales and distribution rights in Singapore and Thailand for seven of its generic finished-dose formulations to an affiliate of DKSH, an Asia-focused services provider based in Switzerland.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Deals

More from Business